POLIVY

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: a38c54377a603788
Drug Approval Canada Name: POLIVY
Product Name: POLIVY
Status: Marketed
Status Date: 2021-10-26
Original Market Date: 2021-10-26
Din: 02515431
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FX14 POLATUZUMAB VEDOTIN
Atc Name: l 01 fx 14
Aig Number: 0162275002
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

POLATUZUMAB VEDOTIN

30 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a38c54377a603788

Type

Standard